News

Phantomics Signs Agreement with Seoul Metropolitan Government for the 2025 Seoul-type Strong SME Program

Phantomics, a medical imaging AI company, has signed an agreement with the Seoul Metropolitan Government to efficiently carry out the 2025 Seoul-type Strong SME support program. Under the agreement, Phantomics will receive a range of support from the city for two years, from January 2025 through the end of 2026.


"Seoul-type Strong SMEs" are small and medium-sized enterprises designated by the city for excellence in job creation, family-friendly organizational culture, employment stability and employee benefits.


Selected as a Seoul-type Strong SME in July 2024, Phantomics will recruit young talent through the Seoul Job Center and receive workplace-improvement grants when hiring young employees on permanent contracts. The city also plans to support corporate promotion and company visits.


Phantomics has established flexible working arrangements and worked to support employees' work-life balance. It runs distinctive programs such as the in-house newsletter "Fan Letter" and a quarterly "Fan Meeting Day," building an organizational culture where young professionals want to work. The city recognized the company as a model SME for youth job creation and work-life balance.


Founded in 2019, Phantomics is a medical imaging AI startup. It developed Myomics, which uses AI to shorten cardiac MRI analysis from 30 minutes to under two minutes while providing biopsy-level diagnostic accuracy. Myomics accurately diagnoses myocardial diseases such as heart failure, myocardial infarction, myocarditis and amyloidosis, helping clinicians reach rapid diagnoses. It has been installed at Severance Hospital, Seoul National University Hospital, Asan Medical Center and Seoul St. Mary's Hospital, where its usefulness has been demonstrated.

⚡ Made with pagesss